Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2014.00163
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Analysis of Gene Expression in Wild-Type and Notch1 Mutant Retinal Cells by Single Cell Profiling

Developmental Dynamics
Developmental Biology
2013English

Stable Cell Lines of Human SH‑SY5Y Uniformly Expressing Wild‑type or Mutant‑type FERM Domain Containing 7 Gene

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis

PLoS ONE
Multidisciplinary
2013English

Differential microRNA Expression Signatures and Cell Type-Specific Association With Taxol Resistance in Ovarian Cancer Cells

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

The Effect of Phosphonoformic Acid Oh Wild Type and Mutant S49 Cell Lines: 1

Pediatric Research
Child HealthPediatricsPerinatology
1985English

Mutant and Wild-Type Ras: Co-Conspirators in Cancer

Cancer Discovery
Oncology
2013English

Differential Gene Expression Profiles of Radioresistant Oesophageal Cancer Cell Lines Established by Continuous Fractionated Irradiation

British Journal of Cancer
Cancer ResearchOncology
2004English

Aminothiol WR1065 Induces Differential Gene Expression in the Presence of Wild-Type P53

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

TP53 Status Determines Clinical Significance of ERBB2 Expression in Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy